Subscribe

Stryker Corporation (SYK)

USD326.54 +13.15 (+4.20%)
US NYSE S&P 500 Healthcare Medical - Devices
Address 1941 Stryker Way 49002
Portage, MI, US
CEO Kevin A. Lobo
IPO 1980-03-17
CIK 310764 ISIN US8636671013

Explore sections of this company profile

Also trades on Deutsche Börse · SYK.DE (EUR) London Stock Exchange · 0R2S.L (USD) New York Stock Exchange · SYK (USD)
Description

Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.

News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History
Target company Ticker Date Filing
Colorado IGTI 2000-06-28 View

Index membership

IndexAddedRemovedStatus
S&P 500 2000-12-11 Active
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD326.54 +13.15 (+4.20%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.78
Float Shares
346.74M
Free Float %
90.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+4.20% +0.15% -15.20% -19.56% -21.15% -16.22% -24.02% +1.91% +18.80% +165.49% +353,232.93%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (50 ratings, all time) Buy
Price Targets & DCF
Current price
326.54
Low 315.00 -3.5%
Consensus 389.62 +19.3%
Median 394.00 +20.7%
High 465.00 +42.4%
DCF (Unlevered) 348.81 +6.8%
DCF (Levered) 375.63 +15.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 76% Bullish
Rating 2026-05 Change
Strong Buy 8 0
Buy 14 0
Hold 7 -1
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 9
371.89
+13.9%
Last Quarter 11
382.91
+17.3%
Last Year 29
406.76
+24.6%
All Time 80
354.78
+8.6%
Quality scores
Altman Z-Score
3.78
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Devices: +11.2%
    +11.2% Q1'26: +2.6% (vs Q1'25)
  • EPS growth Medical - Devices: +28.5%
    +8.3% Q1'26: +14.2% (vs Q1'25)
  • FCF margin FCF growth · Medical - Devices: +30.9%
    +13.2% Q1'26: +6.9% (vs Q1'25)
  • EBIT margin Medical - Devices: +6.2%
    +20.4% Q1'26: +15.5% (vs Q1'25)
  • ROIC Medical - Devices: +3.3%
    +11.1% Q1'26: +9.8% (vs Q1'25)
  • Share dilution Medical - Devices: 0.0%
    -0.9% Q1'26: +0.0% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    2.35× Q1'26: 2.88× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.81) × ERP
WACC = 88% × Ke + 12% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 344.09 Current price: 326.54
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2011
actual
Dec 2012
actual
Dec 2013
actual
Dec 2014
actual
Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
19 Rev. Ana.
16 EPS Ana.
Dec 2027
20 Rev. Ana.
17 EPS Ana.
Dec 2028
18 Rev. Ana.
7 EPS Ana.
Dec 2029
11 Rev. Ana.
2 EPS Ana.
Dec 2030
9 Rev. Ana.
5 EPS Ana.
Revenue
8.31B
est: 8.24B (+0.8%)
8.66B
est: 8.66B (0.0%)
9.02B
est: 9.05B (-0.3%)
9.68B
est: 9.72B (-0.4%)
9.95B
est: 9.94B (+0.0%)
11.33B
est: 11.32B (+0.1%)
12.44B
est: 12.39B (+0.5%)
13.60B
est: 13.54B (+0.4%)
14.88B
est: 14.86B (+0.2%)
14.35B
est: 14.42B (-0.5%)
17.11B
est: 17.06B (+0.3%)
18.45B
est: 18.21B (+1.3%)
20.50B
est: 21.39B (-4.2%)
22.60B
est: 22.52B (+0.3%)
25.12B
est: 25.07B (+0.2%)
27.28B
27.15B – 27.37B
+8.8% YoY
29.61B
29.12B – 30.13B
+8.6% YoY
32.02B
31.99B – 32.05B
+8.1% YoY
35.00B
34.61B – 35.39B
+9.3% YoY
37.95B
37.53B – 38.38B
+8.4% YoY
EBITDA
2.26B
est: 2.17B (+4.4%)
2.05B
est: 1.90B (+7.7%)
1.61B
est: 1.52B (+6.3%)
1.65B
est: 1.54B (+7.1%)
2.24B
est: 2.09B (+7.0%)
2.70B
est: 2.42B (+11.3%)
2.95B
est: 2.66B (+10.9%)
3.34B
est: 3.01B (+10.9%)
3.63B
est: 3.29B (+10.2%)
3.08B
est: 2.13B (+44.8%)
3.61B
est: 3.26B (+10.5%)
4.02B
est: 3.48B (+15.3%)
5.06B
est: 4.90B (+3.2%)
4.94B
est: 5.16B (-4.3%)
6.31B
est: 5.74B (+10.0%)
6.25B
6.22B – 6.27B
+8.8% YoY
6.78B
6.67B – 6.90B
+8.6% YoY
7.33B
7.33B – 7.34B
+8.1% YoY
8.02B
7.93B – 8.11B
+9.3% YoY
8.69B
8.60B – 8.79B
+8.4% YoY
EBIT
1.78B
est: 1.67B (+6.5%)
1.77B
est: 1.74B (+1.6%)
1.31B
est: 1.25B (+4.2%)
1.27B
est: 1.25B (+2.0%)
1.84B
est: 1.83B (+0.8%)
2.15B
est: 2.13B (+1.0%)
2.31B
est: 2.25B (+2.5%)
2.62B
est: 2.48B (+5.5%)
2.85B
est: 2.67B (+6.5%)
2.27B
est: 1.69B (+34.2%)
2.62B
est: 2.58B (+1.6%)
3.02B
est: 2.76B (+9.6%)
4.03B
est: 3.80B (+5.9%)
3.89B
est: 4.01B (-2.9%)
5.12B
est: 4.46B (+14.9%)
4.85B
4.83B – 4.87B
+8.8% YoY
5.27B
5.18B – 5.36B
+8.6% YoY
5.69B
5.69B – 5.70B
+8.1% YoY
6.22B
6.16B – 6.29B
+9.3% YoY
6.75B
6.68B – 6.83B
+8.4% YoY
Net Income
1.35B
est: 1.33B (+0.8%)
1.30B
est: 1.30B (-0.2%)
1.01B
est: 1.00B (+0.2%)
515.00M
est: 517.59M (-0.5%)
1.44B
est: 1.41B (+1.7%)
1.65B
est: 1.62B (+1.9%)
1.02B
est: 994.79M (+2.5%)
3.55B
est: 3.49B (+1.8%)
2.08B
est: 2.05B (+1.5%)
1.60B
est: 1.22B (+31.1%)
1.99B
est: 1.98B (+0.5%)
2.36B
est: 2.16B (+9.1%)
3.17B
est: 3.45B (-8.2%)
2.99B
est: 4.61B (-35.1%)
3.25B
est: 5.18B (-37.4%)
5.72B
5.68B – 5.76B
+10.4% YoY
6.25B
5.92B – 6.58B
+9.2% YoY
7.18B
6.61B – 7.75B
+15.0% YoY
8.09B
7.97B – 8.21B
+12.6% YoY
8.91B
8.78B – 9.04B
+10.1% YoY
SGA
3.08B
est: 3.12B (-1.3%)
3.39B
est: 3.46B (-2.2%)
3.31B
est: 4.08B (-18.9%)
3.38B
est: 3.59B (-5.9%)
3.51B
est: 3.54B (-0.9%)
3.95B
est: 4.06B (-2.7%)
4.35B
est: 4.48B (-2.9%)
4.63B
est: 4.99B (-7.1%)
5.02B
est: 5.28B (-4.8%)
4.82B
est: 4.30B (+12.1%)
5.81B
est: 6.44B (-9.8%)
6.08B
est: 7.00B (-13.2%)
6.92B
est: 7.20B (-3.9%)
7.51B
est: 7.58B (-1.0%)
8.65B
est: 8.44B (+2.5%)
9.18B
9.14B – 9.21B
+8.8% YoY
9.97B
9.80B – 10.14B
+8.6% YoY
10.78B
10.77B – 10.79B
+8.1% YoY
11.78B
11.65B – 11.92B
+9.3% YoY
12.78B
12.64B – 12.92B
+8.4% YoY
EPS
3.48
est: 3.67 (-5.2%)
3.41
est: 4.08 (-16.4%)
2.66
est: 4.26 (-37.6%)
1.36
est: 4.77 (-71.5%)
3.82
est: 5.11 (-25.2%)
4.40
est: 5.78 (-23.9%)
2.73
est: 6.48 (-57.9%)
9.50
est: 7.28 (+30.5%)
5.57
est: 8.23 (-32.3%)
4.26
est: 7.18 (-40.7%)
5.29
est: 9.11 (-41.9%)
6.23
est: 9.18 (-32.1%)
8.34
est: 9.07 (-8.0%)
7.86
est: 12.05 (-34.8%)
8.49
est: 13.56 (-37.4%)
14.98
14.86 – 15.08
+10.4% YoY
16.75
15.48 – 17.22
+11.8% YoY
18.69
17.31 – 20.29
+11.6% YoY
21.16
20.86 – 21.47
+13.2% YoY
23.31
22.97 – 23.65
+10.1% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-04 Barclays Overweight Overweight Maintain
2026-05-01 Evercore ISI Group Outperform Outperform Maintain
2026-04-15 Truist Securities Hold Hold Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5
2026-05-08 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-05-07 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-05-06 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-05-05 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-05-04 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-05-01 B+ 3/5 4/5 3/5 5/5 2/5 2/5 3/5
2026-04-30 B+ 3/5 4/5 3/5 5/5 2/5 2/5 3/5
2026-04-29 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-04-28 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-04-27 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-04-24 B 3/5 4/5 4/5 5/5 1/5 2/5 1/5
2026-04-23 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5
2026-04-22 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5
2026-04-21 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5
2026-04-20 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5
2026-04-17 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5
2026-04-16 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5
2026-04-15 B 3/5 4/5 4/5 5/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
4.74B
OE per share TTM
12.28
Owner's Yield
4.39%
Maintenance CapEx ratio
15.70%
Maint CapEx / Avg PPE
18.3%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
817
Total invested
10.40B
Insider transactions (90d)
0
Beneficial owners (>5%)
12
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Stryker Corporation 30.03M 100.00% 30.03M 30.03M 10.00 CO Michigan 2018-02-28
2 The Vanguard Group - 23-1945930 28.65M 7.60% 552.7K 27.27M 1.39M IA Pennsylvania For 2022-02-10
3 (1) BlackRock, Inc. 23.86M 6.30% 21.03M 23.86M HC Delaware 2022-02-07
4 52-0556948 21.16M 5.50% 8.86M 21.16M IA Maryland 2022-02-14
5 38-3416104 20.45M 5.40% 114.3K 20.34M 110.1K 20.34M BK State of Michigan 2022-02-11
6 John W. Brown 20.06M 5.30% 19.80M 260.0K 19.80M 260.0K IN U.S. 2021-02-09
7 Jon L. Stryker 18.57M 4.70% 3.21M 15.35M 3.21M IN U.S. 2011-01-27
8 First Western Trust Bank 27-0083757 17.14M 4.51% 48.5K 17.09M 48.5K BK U.S. 2012-02-22
9 Capital Research Global Investors ** 13.84M 3.60% 13.84M 13.84M IA Delaware 2019-02-14
10 Owl Acquisition Corporation 10.23M 13.28% 10.23M 10.00 CO Delaware 2011-05-26
11 Tax I.D. # - 98-0201080 8.75M 4.47% 8.75M 8.75M IA Hamilton, Bermuda 2001-02-26
12 Edward C. Johnson 3d 4.16M 4.29% 4.16M IN United States of America 2000-02-14

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
817
-1,546 vs prev Q
New positions
42
Closed positions
1,539
Increased
372
Reduced
315
Put/Call ratio
0.25
Calls held
3.2K
Puts held
800.00
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 VANGUARD GROUP INC 33.91M +133.9K (+0.4%) 11.92B -567.6M (-4.5%) 8.87% +0.035 pp 0.17% -0.014 pp USD167.61 +109.7% 84 qtrs
2 BLACKROCK, INC. 27.45M +720.6K (+2.7%) 9.65B -233.2M (-2.4%) 7.18% +0.189 pp 0.16% -0.010 pp USD361.18 -2.7% 6 qtrs
3 GREENLEAF TRUST 16.56M -79.3K (-0.5%) 5.82B -330.8M (-5.4%) 4.33% -0.021 pp 53.36% -2.570 pp USD69.89 +402.9% 51 qtrs
4 STATE STREET CORP 15.25M +311.5K (+2.1%) 5.37B -161.5M (-2.9%) 3.99% +0.082 pp 0.18% -0.012 pp USD127.85 +174.9% 51 qtrs
5 JPMORGAN CHASE & CO 12.15M +205.0K (+1.7%) 4.27B -145.3M (-3.3%) 3.18% +0.054 pp 0.27% +0.004 pp USD311.90 +12.7% 51 qtrs
6 PRICE T ROWE ASSOCIATES INC /MD/ 10.12M -879.9K (-8.0%) 3.56B -509.4M (-12.5%) 2.65% -0.230 pp 0.38% -0.052 pp USD157.39 +123.3% 75 qtrs
7 GEODE CAPITAL MANAGEMENT, LLC 7.54M +69.9K (+0.9%) 2.64B -110.1M (-4.0%) 1.97% +0.018 pp 0.16% -0.013 pp USD184.77 +90.2% 78 qtrs
8 WELLINGTON MANAGEMENT GROUP LLP 6.49M +1.2M (+22.6%) 2.28B +324.9M (+16.6%) 1.70% +0.314 pp 0.40% +0.057 pp USD263.44 +33.4% 65 qtrs
9 ALLIANCEBERNSTEIN L.P. 6.44M +106.3K (+1.7%) 2.26B -78.0M (-3.3%) 1.69% +0.028 pp 0.72% -0.023 pp USD368.47 -4.6% 61 qtrs
10 MORGAN STANLEY 6.25M -207.0K (-3.2%) 2.20B -190.3M (-8.0%) 1.64% -0.054 pp 0.13% -0.013 pp USD236.23 +48.8% 51 qtrs
11 CAPITAL RESEARCH GLOBAL INVESTORS 5.97M -307.7K (-4.9%) 2.10B -222.4M (-9.6%) 1.56% -0.081 pp 0.39% -0.048 pp USD167.78 +109.5% 51 qtrs
12 NORGES BANK 5.18M +5.2M (+100.0%) 1.82B +1.8B (+100.0%) 1.36% +1.357 pp 0.19% +0.195 pp USD351.47 +0.0% 1 qtrs NEW
13 BANK OF AMERICA CORP /DE/ 4.42M +536.4K (+13.8%) 1.56B +117.8M (+8.2%) 1.16% +0.140 pp 0.11% +0.016 pp USD291.64 +20.5% 52 qtrs
14 BANK OF NEW YORK MELLON CORP 4.31M -225.5K (-5.0%) 1.52B -161.8M (-9.6%) 1.13% -0.059 pp 0.27% -0.056 pp USD76.19 +361.3% 66 qtrs
15 FUNDSMITH LLP 3.69M -903.8K (-19.7%) 1.30B -401.2M (-23.6%) 0.96% -0.237 pp 7.57% -1.002 pp USD132.09 +166.1% 52 qtrs
16 NORTHERN TRUST CORP 3.35M -76.3K (-2.2%) 1.18B -89.1M (-7.0%) 0.88% -0.020 pp 0.15% -0.012 pp USD121.71 +188.8% 51 qtrs
17 FIRST WESTERN TRUST BANK 3.25M -380.0 (0.0%) 1.14B -59.3M (-4.9%) 0.85% 0.000 pp 56.21% +0.981 pp USD267.34 +31.5% 16 qtrs
18 FRANKLIN RESOURCES INC 3.20M -93.2K (-2.8%) 1.12B -92.7M (-7.6%) 0.84% -0.024 pp 0.28% -0.028 pp USD86.33 +307.1% 51 qtrs
19 FISHER ASSET MANAGEMENT, LLC 3.12M -192.8K (-5.8%) 1.10B -128.0M (-10.5%) 0.82% -0.051 pp 0.37% -0.069 pp USD213.84 +64.4% 33 qtrs
20 ROYAL BANK OF CANADA 3.07M -268.5K (-8.0%) 1.08B -155.2M (-12.6%) 0.80% -0.070 pp 0.18% -0.027 pp USD294.24 +19.5% 51 qtrs
21 FMR LLC 2.98M -2.2M (-42.1%) 1.05B -854.0M (-44.9%) 0.78% -0.566 pp 0.05% -0.046 pp USD280.57 +25.3% 70 qtrs
22 LEGAL & GENERAL GROUP PLC 2.37M +62.8K (+2.7%) 831.62M -19.8M (-2.3%) 0.62% +0.016 pp 0.18% -0.007 pp USD165.13 +112.8% 75 qtrs
23 WELLS FARGO & COMPANY/MN 2.26M -30.9K (-1.4%) 792.97M -52.5M (-6.2%) 0.59% -0.008 pp 0.14% -0.016 pp USD150.08 +134.2% 57 qtrs
24 GOLDMAN SACHS GROUP INC 2.15M -295.4K (-12.1%) 755.62M -148.3M (-16.4%) 0.56% -0.077 pp 0.09% -0.018 pp USD263.31 +33.5% 73 qtrs
25 JANUS HENDERSON GROUP PLC 2.08M +444.6K (+27.3%) 729.42M +126.6M (+21.0%) 0.54% +0.116 pp 0.33% +0.051 pp USD265.76 +32.3% 88 qtrs
26 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.07M +30.2K (+1.5%) 729.16M -26.6M (-3.5%) 0.54% +0.008 pp 0.11% -0.007 pp USD172.84 +103.3% 100 qtrs
27 PARNASSUS INVESTMENTS, LLC 1.95M +366.1K (+23.1%) 684.51M +99.9M (+17.1%) 0.51% +0.096 pp 1.78% +0.424 pp USD359.42 -2.2% 6 qtrs
28 UBS ASSET MANAGEMENT AMERICAS INC 1.87M +27.4K (+1.5%) 656.41M -23.9M (-3.5%) 0.49% +0.007 pp 0.14% -0.009 pp USD242.51 +44.9% 90 qtrs
29 CLEARBRIDGE INVESTMENTS, LLC 1.70M -105.9K (-5.9%) 597.98M -70.1M (-10.5%) 0.45% -0.028 pp 0.48% -0.024 pp USD218.46 +60.9% 62 qtrs
30 INVESCO LTD. 1.68M -180.8K (-9.7%) 591.91M -97.5M (-14.1%) 0.44% -0.047 pp 0.09% -0.018 pp USD240.62 +46.1% 57 qtrs
31 NUVEEN, LLC 1.57M +44.9K (+2.9%) 550.91M -11.9M (-2.1%) 0.41% +0.012 pp 0.14% -0.004 pp USD371.61 -5.4% 4 qtrs
32 MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.49M +216.6K (+17.0%) 524.52M +53.5M (+11.4%) 0.39% +0.057 pp 0.43% +0.044 pp USD265.27 +32.5% 99 qtrs
33 UBS GROUP AG 1.47M +66.4K (+4.7%) 517.35M -2.3M (-0.4%) 0.39% +0.017 pp 0.08% +0.003 pp USD297.17 +18.3% 45 qtrs
34 SCHRODER INVESTMENT MANAGEMENT GROUP 1.43M -77.5K (-5.2%) 501.11M -54.6M (-9.8%) 0.37% -0.020 pp 0.38% -0.051 pp USD309.56 +13.5% 51 qtrs
35 AMERIPRISE FINANCIAL INC 1.34M +30.2K (+2.3%) 472.33M -11.7M (-2.4%) 0.35% +0.008 pp 0.11% -0.004 pp USD227.69 +54.4% 55 qtrs
36 FUNDSMITH INVESTMENT SERVICES LTD. 1.31M -246.4K (-15.9%) 459.51M -114.9M (-20.0%) 0.34% -0.065 pp 8.41% -0.545 pp USD269.90 +30.2% 19 qtrs
37 WINSLOW CAPITAL MANAGEMENT, LLC 1.30M +356.8K (+37.9%) 458.56M +110.1M (+31.6%) 0.34% +0.093 pp 1.54% +0.388 pp USD358.57 -2.0% 6 qtrs
38 DIMENSIONAL FUND ADVISORS LP 1.26M +327.5K (+35.1%) 443.11M +98.2M (+28.5%) 0.33% +0.086 pp 0.09% +0.019 pp USD226.30 +55.3% 51 qtrs
39 BARCLAYS PLC 1.17M +166.7K (+16.6%) 410.75M +48.8M (+13.5%) 0.31% +0.044 pp 0.10% +0.006 pp USD319.98 +9.8% 51 qtrs
40 LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 1.15M -4.2K (-0.4%) 409.09M -34.5M (-7.8%) 0.30% -0.001 pp 3.71% -0.185 pp USD62.24 +464.7% 83 qtrs
41 DEUTSCHE BANK AG\ 1.16M +43.4K (+3.9%) 407.39M -5.1M (-1.2%) 0.30% +0.011 pp 0.13% -0.006 pp USD266.47 +31.9% 50 qtrs
42 NORDEA INVESTMENT MANAGEMENT AB 1.10M -6.1K (-0.6%) 386.71M -19.2M (-4.7%) 0.29% -0.002 pp 0.33% -0.023 pp USD278.43 +26.2% 85 qtrs
43 AMERICAN CENTURY COMPANIES INC 1.01M +94.4K (+10.3%) 356.47M +16.4M (+4.8%) 0.27% +0.025 pp 0.18% +0.006 pp USD334.62 +5.0% 29 qtrs
44 PNC FINANCIAL SERVICES GROUP, INC. 997.5K -32.6K (-3.2%) 350.58M -30.2M (-7.9%) 0.26% -0.009 pp 0.19% -0.040 pp USD130.05 +170.3% 51 qtrs
45 RAYMOND JAMES FINANCIAL INC 986.7K +33.8K (+3.6%) 346.83M -5.4M (-1.5%) 0.26% +0.009 pp 0.11% -0.005 pp USD359.78 -2.3% 5 qtrs
46 CI PRIVATE WEALTH, LLC 981.4K +31.4K (+3.3%) 345.02M -6.2M (-1.8%) 0.26% +0.008 pp 0.46% -0.089 pp USD273.72 +28.4% 13 qtrs
47 AMUNDI 974.2K -7.5K (-0.8%) 342.42M -17.2M (-4.8%) 0.25% -0.002 pp 0.09% -0.023 pp USD309.91 +13.4% 19 qtrs
48 BLUESPRUCE INVESTMENTS, LP 943.6K +62.9K (+7.1%) 331.66M +6.1M (+1.9%) 0.25% +0.016 pp 8.46% +0.987 pp USD361.47 -2.8% 7 qtrs
49 SWISS NATIONAL BANK 942.9K -48.6K (-4.9%) 331.39M -35.1M (-9.6%) 0.25% -0.013 pp 0.20% -0.015 pp USD158.89 +121.2% 51 qtrs
50 BNP PARIBAS ARBITRAGE, SNC 913.2K +187.7K (+25.9%) 320.95M +52.8M (+19.7%) 0.24% +0.049 pp 0.15% +0.002 pp USD323.94 +8.5% 51 qtrs
51 CIBC PRIVATE WEALTH GROUP, LLC 853.9K -29.0K (-3.3%) 300.11M -26.2M (-8.0%) 0.22% -0.008 pp 0.51% -0.051 pp USD188.56 +86.4% 48 qtrs
52 1832 ASSET MANAGEMENT L.P. 845.6K +608.1K (+256.1%) 297.19M +209.4M (+238.6%) 0.22% +0.159 pp 0.23% +0.157 pp USD346.86 +1.3% 31 qtrs
53 BLAIR WILLIAM & CO/IL 844.9K -74.6K (-8.1%) 296.96M -43.0M (-12.6%) 0.22% -0.020 pp 0.80% -0.108 pp USD168.96 +108.0% 51 qtrs
54 MACKENZIE FINANCIAL CORP 820.0K -423.6K (-34.1%) 289.81M -169.9M (-37.0%) 0.21% -0.111 pp 0.34% -0.214 pp USD324.86 +8.2% 40 qtrs
55 SUMITOMO MITSUI TRUST HOLDINGS, INC. 815.0K +20.0K (+2.5%) 286.44M -7.4M (-2.5%) 0.21% +0.005 pp 0.17% -0.001 pp USD155.52 +126.0% 59 qtrs
56 BANK JULIUS BAER & CO. LTD, ZURICH 807.5K +34.8K (+4.5%) 284.14M -1.5M (-0.5%) 0.21% +0.009 pp 0.78% -0.021 pp USD351.13 +0.1% 24 qtrs
57 DEKABANK DEUTSCHE GIROZENTRALE 752.7K +— (+0.0%) 279.57M +2.7M (+1.0%) 0.20% +0.000 pp 0.48% +0.017 pp USD245.68 +43.1% 66 qtrs
58 APG ASSET MANAGEMENT N.V. 931.0K -12.6K (-1.3%) 278.62M -18.3M (-6.2%) 0.24% -0.003 pp 0.79% -0.043 pp USD368.36 -4.6% 51 qtrs
59 JENSEN INVESTMENT MANAGEMENT INC 731.5K -488.5K (-40.0%) 257.12M -193.9M (-43.0%) 0.19% -0.128 pp 4.05% -1.551 pp USD155.82 +125.6% 51 qtrs
60 MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 723.7K +24.4K (+3.5%) 251.98M -6.5M (-2.5%) 0.19% +0.006 pp 0.17% -0.015 pp USD299.89 +17.2% 58 qtrs
61 NATIONAL PENSION SERVICE 706.4K +22.5K (+3.3%) 248.27M -4.5M (-1.8%) 0.18% +0.006 pp 0.18% -0.013 pp USD219.37 +60.2% 46 qtrs
62 CANADA PENSION PLAN INVESTMENT BOARD 697.7K +131.9K (+23.3%) 245.23M +36.0M (+17.2%) 0.18% +0.035 pp 0.16% +0.017 pp USD358.34 -1.9% 52 qtrs
63 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 674.4K -173.8K (-20.5%) 237.02M -76.5M (-24.4%) 0.18% -0.046 pp 0.14% -0.052 pp USD270.74 +29.8% 58 qtrs
64 QUBE RESEARCH & TECHNOLOGIES LTD 650.6K +213.4K (+48.8%) 228.65M +67.0M (+41.5%) 0.17% +0.056 pp 0.23% +0.065 pp USD362.79 -3.1% 11 qtrs
65 ACADIAN ASSET MANAGEMENT LLC 636.8K +399.2K (+168.0%) 223.78M +136.0M (+154.8%) 0.17% +0.105 pp 0.37% +0.214 pp USD355.52 -1.1% 43 qtrs
66 STIFEL FINANCIAL CORP 633.4K -46.2K (-6.8%) 222.63M -28.6M (-11.4%) 0.17% -0.012 pp 0.20% -0.029 pp USD247.52 +42.0% 48 qtrs
67 RHUMBLINE ADVISERS 627.9K -8.1K (-1.3%) 220.69M -14.4M (-6.1%) 0.16% -0.002 pp 0.18% -0.010 pp USD120.63 +191.4% 55 qtrs
68 TD ASSET MANAGEMENT INC 615.1K -380.0K (-38.2%) 216.20M -151.7M (-41.2%) 0.16% -0.099 pp 0.17% -0.125 pp USD211.93 +65.8% 51 qtrs
69 HSBC HOLDINGS PLC 608.6K -8.7K (-1.4%) 214.06M -14.0M (-6.1%) 0.16% -0.002 pp 0.11% -0.017 pp USD286.58 +22.6% 56 qtrs
70 MARINER, LLC 606.4K +1.3K (+0.2%) 213.14M -10.5M (-4.7%) 0.16% +0.000 pp 0.25% -0.035 pp USD255.90 +37.3% 56 qtrs
71 ENSIGN PEAK ADVISORS, INC 600.9K -16.5K (-2.7%) 211.20M -17.0M (-7.5%) 0.16% -0.004 pp 0.37% -0.001 pp USD213.58 +64.6% 25 qtrs
72 ABN AMRO BANK N.V. 595.1K -78.9K (-11.7%) 208.66M -39.5M (-15.9%) 0.16% -0.021 pp 1.96% -0.477 pp USD364.03 -3.5% 5 qtrs
73 SG AMERICAS SECURITIES, LLC 566.5K +493.6K (+676.8%) 199.12M +172.2M (+638.6%) 0.15% +0.129 pp 0.25% +0.163 pp USD356.55 -1.4% 51 qtrs
74 PRINCIPAL FINANCIAL GROUP INC 552.7K +176.4K (+46.9%) 194.25M +55.1M (+39.6%) 0.14% +0.046 pp 0.10% +0.029 pp USD204.08 +72.2% 81 qtrs
75 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 545.3K -5.9K (-1.1%) 191.67M -12.1M (-5.9%) 0.14% -0.002 pp 0.19% -0.017 pp USD111.31 +215.8% 52 qtrs
76 FENIMORE ASSET MANAGEMENT INC 525.4K -59.0 (0.0%) 184.65M -9.6M (-4.9%) 0.14% +0.000 pp 3.85% -0.049 pp USD64.95 +441.1% 68 qtrs
77 CITADEL ADVISORS LLC 521.5K +153.7K (+41.8%) 183.29M +47.3M (+34.8%) 0.14% +0.040 pp 0.03% +0.007 pp USD364.31 -3.5% 2 qtrs
78 PRIMECAP MANAGEMENT CO/CA/ 516.8K +8.3K (+1.6%) 181.64M -6.3M (-3.4%) 0.14% +0.002 pp 0.14% -0.007 pp USD177.34 +98.2% 56 qtrs
79 SEI INVESTMENTS CO 514.8K +87.2K (+20.4%) 180.93M +22.8M (+14.4%) 0.13% +0.023 pp 0.18% +0.009 pp USD337.25 +4.2% 45 qtrs
80 WELCH & FORBES LLC 512.5K -1.1K (-0.2%) 180.12M -9.7M (-5.1%) 0.13% 0.000 pp 2.18% -0.105 pp USD53.50 +557.0% 88 qtrs
81 CREDIT AGRICOLE S A 501.7K -23.2K (-4.4%) 176.32M -17.7M (-9.1%) 0.13% -0.006 pp 0.40% -0.114 pp USD369.67 -4.9% 2 qtrs
82 BANK OF MONTREAL /CAN/ 500.8K +22.4K (+4.7%) 176.02M -829.2K (-0.5%) 0.13% +0.006 pp 0.06% -0.007 pp USD253.78 +38.5% 51 qtrs
83 D. E. SHAW & CO., INC. 488.7K +372.0K (+318.9%) 171.75M +128.6M (+298.3%) 0.13% +0.097 pp 0.09% +0.070 pp USD349.48 +0.6% 10 qtrs
84 ALECTA TJANSTEPENSION OMSESIDIGT 487.5K +29.2K (+6.4%) 171.32M +1.9M (+1.1%) 0.13% +0.008 pp 0.75% -0.002 pp USD376.49 -6.6% 5 qtrs
85 ENVESTNET ASSET MANAGEMENT INC 482.6K -109.8K (-18.5%) 169.61M -49.4M (-22.5%) 0.13% -0.029 pp 0.05% -0.013 pp USD230.17 +52.7% 51 qtrs
86 KING LUTHER CAPITAL MANAGEMENT CORP 481.3K +19.6K (+4.2%) 169.15M -1.5M (-0.9%) 0.13% +0.005 pp 0.69% -0.015 pp USD239.88 +46.5% 23 qtrs
87 WORLDQUANT MILLENNIUM ADVISORS LLC 478.3K +428.0K (+852.2%) 168.09M +149.5M (+805.3%) 0.13% +0.112 pp 0.65% +0.572 pp USD353.38 -0.5% 2 qtrs
88 PICTET ASSET MANAGEMENT HOLDING SA 466.3K +305.6K (+190.3%) 163.88M +104.5M (+176.0%) 0.12% +0.080 pp 0.16% +0.102 pp USD328.20 +7.1% 10 qtrs
89 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 455.0K +432.5K (+1,925.0%) 159.91M +151.6M (+1,825.3%) 0.12% +0.113 pp 0.09% +0.088 pp USD352.37 -0.3% 21 qtrs
90 UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 448.4K +19.1K (+4.5%) 158.01M -657.9K (-0.4%) 0.12% +0.005 pp 0.26% -0.007 pp USD360.46 -2.5% 5 qtrs
91 HIGHTOWER ADVISORS, LLC 444.5K +441.0 (+0.1%) 156.24M -7.9M (-4.8%) 0.12% +0.000 pp 0.17% -0.016 pp USD232.56 +51.1% 59 qtrs
92 LORD, ABBETT & CO. LLC 436.5K -343.0 (-0.1%) 153.43M -8.1M (-5.0%) 0.11% 0.000 pp 0.47% -0.010 pp USD382.53 -8.1% 10 qtrs
93 STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD 434.7K -14.8K (-3.3%) 152.77M -13.4M (-8.0%) 0.11% -0.004 pp 4.70% -0.013 pp USD337.11 +4.3% 11 qtrs
94 CITIGROUP INC 430.2K -61.7K (-12.5%) 151.22M -30.6M (-16.8%) 0.11% -0.016 pp 0.07% -0.014 pp USD310.13 +13.3% 108 qtrs
95 SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 419.8K +71.3K (+20.5%) 147.55M +18.7M (+14.5%) 0.11% +0.019 pp 0.59% +0.075 pp USD338.57 +3.8% 41 qtrs
96 LPL FINANCIAL LLC 411.2K +9.6K (+2.4%) 144.54M -3.9M (-2.6%) 0.11% +0.003 pp 0.04% -0.004 pp USD282.07 +24.6% 51 qtrs
97 RENAISSANCE TECHNOLOGIES LLC 406.2K +303.0K (+293.6%) 142.75M +104.6M (+274.2%) 0.11% +0.079 pp 0.22% +0.171 pp USD356.09 -1.3% 2 qtrs
98 FIL LTD 404.1K +9.5K (+2.4%) 142.01M -3.9M (-2.6%) 0.11% +0.003 pp 0.11% -0.008 pp USD245.40 +43.2% 40 qtrs
99 CCLA INVESTMENT MANAGEMENT 401.9K +17.8K (+4.6%) 141.25M -729.0K (-0.5%) 0.11% +0.005 pp 2.27% -0.005 pp USD248.83 +41.2% 14 qtrs
100 NEW YORK STATE COMMON RETIREMENT FUND 397.2K -28.1K (-6.6%) 139.62M -17.6M (-11.2%) 0.10% -0.007 pp 0.19% -0.017 pp USD72.92 +382.0% 103 qtrs
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.66
Neutral
Ratio by volume
0.30
Bearish
Buys
21
Sells
32
Shares acquired
470.5K
Shares disposed
1.59M
Cash buys
Cash sales
19.00
Net activity
-1,121,335
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-21 Wells Preston Wendell Officer F-InKind D Common Stock 204 335.67 68.5K 6,498 D
2026-03-21 Stiles Spencer S Officer M-Exempt A Common Stock 430 0.00 84,324 D
2026-03-21 Pierce James Andrew Officer M-Exempt D Dividend Equivalents 430 0.00 0 D
2026-03-21 Menon Viju Officer M-Exempt D Dividend Equivalents 269 0.00 0 D
2026-03-21 Lobo Kevin Director / Officer M-Exempt D Dividend Equivalents 1,452 0.00 0 D
2026-03-21 Fletcher Robert S Officer M-Exempt D Dividend Equivalents 225 0.00 0 D
2026-03-21 Fink M Kathryn Officer M-Exempt D Dividend Equivalents 150 0.00 0 D
2026-03-21 Crotty Dylan Bram Officer F-InKind D Common Stock 368 335.67 123.5K 5,474 D
2026-03-21 Berry William E Jr Officer F-InKind D Common Stock 176 335.67 59.1K 3,426 D
2026-03-09 Pierce James Andrew Officer A-Award A Common Stock 14,912 0.00 88,246 D
2026-03-09 Menon Viju Officer A-Award A Common Stock 9,320 0.00 21,831 D
2026-03-09 Lobo Kevin Director / Officer A-Award A Common Stock 50,332 0.00 247,271 D
2026-02-23 STRYKER RONDA E Director G-Gift D Common Stock 55,600 0.00 2,231,173 I
2026-02-17 STRYKER RONDA E Director J-Other D Common Stock 42,000 0.00 12,857,163 I
2026-02-13 STRYKER RONDA E Director G-Gift D Common Stock 377,900 0.00 2,509,073 I
2026-02-06 Lobo Kevin Director / Officer M-Exempt D Employee Stock Option granted 02/10/2016 (right to buy) 206,955 96.64 20.00M 0 D
2026-02-05 STRYKER RONDA E Director S-Sale D Common Stock 6,342 366.99 2.33M 2,207,331 I
2026-02-04 Wells Preston Wendell Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 11,974 360.82 4.32M 11,974 D
2026-02-04 Stiles Spencer S Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 19,956 360.82 7.20M 19,956 D
2026-02-04 STRYKER RONDA E Director S-Sale D Common Stock 2,160 368.56 796.1K 2,457,331 I
2026-02-04 Pierce James Andrew Officer A-Award A Common Stock 2,771 0.00 73,334 D
2026-02-04 Montagnino Kimberly Ann Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 1,830 360.82 660.3K 1,830 D
2026-02-04 Menon Viju Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 10,310 360.82 3.72M 10,310 D
2026-02-04 Lobo Kevin Director / Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 58,206 360.82 21.00M 58,206 D
2026-02-04 King Debra Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 3,992 360.82 1.44M 3,992 D
2026-02-04 Fletcher Robert S Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 8,980 360.82 3.24M 8,980 D
2026-02-04 Fink M Kathryn Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 5,654 360.82 2.04M 5,654 D
2026-02-04 Crotty Dylan Bram Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 9,978 360.82 3.60M 9,978 D
2026-02-04 Berry William E Jr Officer A-Award A Employee Stock Option granted 02/04/2026 (right to buy) 2,391 360.82 862.7K 2,391 D
2026-02-03 Stiles Spencer S Officer F-InKind D Common Stock 7,692 368.14 2.83M 68,982 D
2026-02-02 Pierce James Andrew Officer M-Exempt A Common Stock 13,840 96.64 1.34M 79,470 D
2026-01-15 Silvernail Andrew K Director F-InKind D Common Stock 1,229 359.39 441.7K 17,703 D
2026-01-14 STRYKER RONDA E Director M-Exempt A Common Stock 4,570 96.64 441.6K 5,783 D
2026-01-01 Crotty Dylan Bram Officer Employee Stock Option granted 02/07/2018 (right to buy) 5,515 154.14 850.1K 0 D
2025-12-16 Fink M Kathryn Officer F-InKind D Common Stock 37 355.31 13.1K 13,331 D
2025-12-16 Berry William E Jr Officer F-InKind D Common Stock 28 355.31 9.9K 2,805 D
2025-11-21 Pierce James Andrew Officer G-Gift A Common Stock 106 0.00 713 I
2025-11-20 Wells Preston Wendell Officer S-Sale D Common Stock 165 365.88 60.4K 6,694 D
2025-11-14 Berry William E Jr Officer M-Exempt A Common Stock 4,925 154.14 759.1K 7,758 D
2025-11-06 STRYKER RONDA E Director S-Sale D Common Stock 3,819 351.30 1.34M 2,974,066 I
2025-11-05 STRYKER RONDA E Director S-Sale D Common Stock 180 359.79 64.8K 2,978,281 I
2025-11-01 Wells Preston Wendell Officer F-InKind D Common Stock 404 356.24 143.9K 6,859 D
2025-08-25 Menon Viju Officer S-Sale D Common Stock 500 390.61 195.3K 12,511 D
2025-08-20 Fletcher Robert S Officer S-Sale D Common Stock 1,785 393.07 701.6K 10,457 D
2025-08-06 STRYKER RONDA E Director S-Sale D Common Stock 10,428 378.54 3.95M 3,230,748 I
2025-08-05 King Debra Officer A-Award A Common Stock 6,553 0.00 6,553 D
2025-08-05 Fink M Kathryn Officer A-Award A Common Stock 917 0.00 13,367 D
2025-08-01 Montagnino Kimberly Ann Officer F-InKind D Common Stock 155 392.73 60.9K 1,195 D
2025-08-01 Fletcher Robert S Officer F-InKind D Common Stock 441 392.73 173.2K 12,242 D
2025-05-27 King Debra Officer 0 0.00 0
2025-05-12 Berry William E Jr Officer S-Sale D Common Stock 1,241 388.56 482.2K 2,833 D
2025-05-08 Suri Rajeev Director A-Award A Common Stock 560 0.00 6,428 D
2025-05-08 Skeete Tatum Lisa M Director A-Award A Common Stock 560 0.00 4,443 D
2025-05-08 Silvernail Andrew K Director A-Award A Common Stock 560 0.00 14,362 D
2025-05-08 STRYKER RONDA E Director / 10% Owner A-Award A Common Stock 560 0.00 1,213 D
2025-05-08 Ruggeri Rachel Director A-Award A Common Stock 560 0.00 1,239 D
2025-05-08 McCoy Sherilyn S Director A-Award A Common Stock 560 0.00 6,428 D
2025-05-08 Maceda Emmanuel Perez Director 0 0.00 0
2025-05-08 Caforio Giovanni Director A-Award A Common Stock 560 0.00 3,768 D
2025-05-08 BRAINERD MARY K Director A-Award A Common Stock 560 0.00 7,028 D
2025-05-06 STRYKER RONDA E Director / 10% Owner S-Sale D Common Stock 18,362 374.76 6.88M 3,596,664 I
2025-04-01 Wells Preston Wendell Officer Employee Stock Option granted 02/07/2018 (right to buy) 1,555 154.14 239.7K 0 D
2025-04-01 Montagnino Kimberly Ann Officer Employee Stock Option granted 02/05/2025 (right to buy) 1,376 392.39 539.9K 0 D
2025-03-21 Stiles Spencer S Officer M-Exempt D Dividend Equivalents 314 0.00 0 D
2025-03-21 Pierce James Andrew Officer M-Exempt D Dividend Equivalents 314 0.00 0 D
2025-03-21 Menon Viju Officer M-Exempt D Dividend Equivalents 187 0.00 0 D
2025-03-21 Lobo Kevin Director / Officer M-Exempt D Dividend Equivalents 1,085 0.00 0 D
2025-03-21 Fletcher Robert S Officer F-InKind D Common Stock 2,578 374.22 964.7K 12,683 D
2025-03-21 Fink M Kathryn Officer M-Exempt A Common Stock 102 0.00 14,157 D
2025-03-21 Boehnlein Glenn S Officer M-Exempt A Common Stock 314 0.00 18,358 D
2025-03-21 Berry William E Jr Officer F-InKind D Common Stock 192 374.22 71.9K 5,581 D
2025-03-21 Becker Yin C Officer M-Exempt A Common Stock 42 0.00 34,586 D
2025-03-10 Stiles Spencer S Officer A-Award A Common Stock 12,916 0.00 68,289 D
2025-03-10 Pierce James Andrew Officer A-Award A Common Stock 12,916 0.00 72,247 D
2025-03-10 Menon Viju Officer A-Award A Common Stock 7,678 0.00 16,747 D
2025-03-10 Lobo Kevin Director / Officer A-Award A Common Stock 44,507 0.00 144,540 D
2025-03-10 Fletcher Robert S Officer A-Award A Common Stock 5,935 0.00 15,117 D
2025-03-10 Fink M Kathryn Officer A-Award A Common Stock 4,189 0.00 14,055 D
2025-03-10 Boehnlein Glenn S Officer A-Award A Common Stock 12,916 0.00 18,044 D
2025-03-10 Becker Yin C Officer A-Award A Common Stock 1,746 0.00 34,544 D
2025-02-27 Becker Yin C Officer M-Exempt A Common Stock 4,980 96.64 481.3K 35,729 D
2025-02-25 STRYKER RONDA E Director / 10% Owner G-Gift D Common Stock 141,026 0.00 3,615,026 I
2025-02-24 STRYKER RONDA E Director / 10% Owner G-Gift D Common Stock 51,282 0.00 3,756,052 I
2025-02-21 STRYKER RONDA E Director / 10% Owner G-Gift D Common Stock 192,308 0.00 3,666,308 I
2025-02-19 STRYKER RONDA E Director / 10% Owner G-Gift D Common Stock 156,411 0.00 3,858,616 I
2025-02-18 Golston Allan C. Director M-Exempt A Common Stock 3,605 122.51 441.6K 18,500 D
2025-02-14 STRYKER RONDA E Director / 10% Owner G-Gift D Common Stock 15,385 0.00 3,999,642 I
2025-02-13 STRYKER RONDA E Director / 10% Owner G-Gift D Common Stock 307,691 0.00 3,299,776 I
2025-02-11 STRYKER RONDA E Director / 10% Owner G-Gift D Common Stock 307,691 0.00 3,299,776 I
2025-02-05 Stiles Spencer S Officer A-Award A Employee Stock Option granted 02/05/2025 (right to buy) 13,458 392.39 5.28M 13,458 D
2025-02-05 Pierce James Andrew Officer A-Award A Employee Stock Option granted 02/05/2025 (right to buy) 13,458 392.39 5.28M 13,458 D
2025-02-05 Menon Viju Officer A-Award A Employee Stock Option granted 02/05/2025 (right to buy) 8,258 392.39 3.24M 8,258 D
2025-02-05 Lobo Kevin Director / Officer A-Award A Employee Stock Option granted 02/05/2025 (right to buy) 48,936 392.39 19.20M 48,936 D
2025-02-05 Fletcher Robert S Officer A-Award A Employee Stock Option granted 02/05/2025 (right to buy) 7,646 392.39 3.00M 7,646 D
2025-02-05 Fink M Kathryn Officer A-Award A Employee Stock Option granted 02/05/2025 (right to buy) 4,894 392.39 1.92M 4,894 D
2025-02-05 Berry William E Jr Officer A-Award A Employee Stock Option granted 02/05/2025 (right to buy) 2,198 392.39 862.5K 2,198 D
2025-02-03 Silvernail Andrew K Director M-Exempt A Common Stock 3,795 93.06 353.2K 14,705 D
2025-01-31 STRYKER RONDA E Director / 10% Owner S-Sale D Common Stock 96,728 390.89 37.81M 3,746,739 I
2025-01-30 STRYKER RONDA E Director / 10% Owner M-Exempt A Common Stock 3,795 93.06 353.2K 7,735 D
2025-01-29 Stiles Spencer S Officer F-InKind D Common Stock 5,448 395.15 2.15M 55,373 D
2025-01-29 Pierce James Andrew Officer M-Exempt D Employee Stock Option granted 02/11/2015 (right to buy) 9,455 93.06 879.9K 0 D
2024-12-31 Boehnlein Glenn S Officer M-Exempt D Employee Stock Option granted 2/8/2017 (right to buy) 300 122.51 36.8K 9,015 D
2024-12-27 Boehnlein Glenn S Officer M-Exempt D Employee Stock Option granted 2/8/2017 (right to buy) 2,000 122.51 245.0K 9,315 D
2024-12-23 Pierce James Andrew Officer G-Gift D Common Stock 198 0.00 55,413 D
2024-12-17 Berry William E Jr Officer F-InKind D Common Stock 30 372.70 11.2K 5,040 D
2024-11-18 Boehnlein Glenn S Officer F-InKind D Common Stock 2,979 390.08 1.16M 4,373 D
2024-11-15 Stiles Spencer S Officer S-Sale D Common Stock 514 391.16 201.1K 50,611 D
2024-11-14 Stiles Spencer S Officer G-Gift D Common Stock 129 0.00 51,125 D
2024-11-07 Lobo Kevin Director / Officer M-Exempt A Common Stock 156,890 93.06 14.60M 256,917 D
2024-11-05 STRYKER RONDA E Director / 10% Owner S-Sale D Common Stock 49,028 367.60 18.02M 3,186,635 I
2024-11-05 Becker Yin C Officer F-InKind D Common Stock 3,189 366.90 1.17M 30,749 D
2024-10-01 Stiles Spencer S Officer F-InKind D Common Stock 552 361.26 199.4K 51,254 D
2024-10-01 Pierce James Andrew Officer F-InKind D Common Stock 641 361.26 231.6K 55,611 D
2024-09-17 Fink M Kathryn Officer S-Sale D Common Stock 635 364.57 231.5K 14,686
2024-09-16 Fink M Kathryn Officer M-Exempt A Common Stock 7,347 122.51 900.1K 17,389
2024-09-13 Fink M Kathryn Officer S-Sale D Common Stock 2,121 370.00 784.8K 10,042
2024-08-28 Berry William E Jr Officer A-Award A Common Stock 1,255 0.00 5,070
2024-08-27 Menon Viju Officer S-Sale D Common Stock 600 355.00 213.0K 9,069
2024-08-06 STRYKER RONDA E Director / 10% Owner S-Sale D Common Stock 3,944 321.43 1.27M 3,487,786
2024-08-06 Fletcher Robert S Officer A-Award A Common Stock 633 0.00 9,182
2024-08-02 Boehnlein Glenn S Officer S-Sale D Common Stock 20,000 333.00 6.66M 2,852
2024-08-01 Fletcher Robert S Officer F-InKind D Common Stock 347 327.45 113.6K 8,549
2024-07-02 Boehnlein Glenn S Officer M-Exempt A Common Stock 25,000 122.51 3.06M 40,012
2024-05-22 Fletcher Robert S Officer S-Sale D Common Stock 2,007 332.99 668.3K 8,896
2024-05-15 Boehnlein Glenn S Officer S-Sale D Common Stock 10,000 327.65 3.28M 15,012
2024-05-09 Suri Rajeev Director A-Award A Common Stock 653 0.00 5,868
2024-05-09 Skeete Tatum Lisa M Director A-Award A Common Stock 653 0.00 3,883
2024-05-09 Silvernail Andrew K Director A-Award A Common Stock 653 0.00 10,910
2024-05-09 STRYKER RONDA E Director / 10% Owner A-Award A Common Stock 653 0.00 3,940
2024-05-09 Ruggeri Rachel Director A-Award A Common Stock 653 0.00 679
2024-05-09 McCoy Sherilyn S Director A-Award A Common Stock 653 0.00 5,868
2024-05-09 Golston Allan C. Director A-Award A Common Stock 653 0.00 14,895
2024-05-09 Caforio Giovanni Director A-Award A Common Stock 653 0.00 3,208
2024-05-09 BRAINERD MARY K Director A-Award A Common Stock 653 0.00 6,468
2024-05-01 Menon Viju Officer F-InKind D Common Stock 649 336.50 218.4K 9,669
2024-05-01 Fink M Kathryn Officer F-InKind D Common Stock 140 336.50 47.1K 12,163
2024-05-01 Boehnlein Glenn S Officer F-InKind D Common Stock 585 336.50 196.9K 25,012
2024-05-01 Becker Yin C Officer F-InKind D Common Stock 148 336.50 49.8K 28,958
2024-03-21 Stiles Spencer S Officer M-Exempt D Dividend Equivalents 203 0.00 0
2024-03-21 Pierce James Andrew Officer M-Exempt D Dividend Equivalents 203 0.00 0
2024-03-21 Menon Viju Officer M-Exempt D Dividend Equivalents 158 0.00 0
2024-03-21 Lobo Kevin Director / Officer M-Exempt D Dividend Equivalents 905 0.00 0
2024-03-21 Fletcher Robert S Officer M-Exempt D Dividend Equivalents 120 0.00 0
2024-03-21 Fink M Kathryn Officer M-Exempt D Dividend Equivalents 83 0.00 0
2024-03-21 Boehnlein Glenn S Officer F-InKind D Common Stock 5,555 353.19 1.96M 25,597
2024-03-21 Berry William E Jr Officer F-InKind D Common Stock 335 353.19 118.3K 3,815
2024-03-21 Becker Yin C Officer M-Exempt D Dividend Equivalents 36 0.00 0
2024-03-11 Stiles Spencer S Officer A-Award A Common Stock 8,499 0.00 55,399
2024-03-11 Pierce James Andrew Officer A-Award A Common Stock 8,499 0.00 60,461
2024-03-11 Menon Viju Officer A-Award A Common Stock 6,610 0.00 13,604
2024-03-11 Lobo Kevin Director / Officer A-Award A Common Stock 37,773 0.00 118,814
2024-03-11 Fletcher Robert S Officer A-Award A Common Stock 5,035 0.00 13,023
2024-03-11 Fink M Kathryn Officer A-Award A Common Stock 3,463 0.00 13,627
2024-03-11 Boehnlein Glenn S Officer A-Award A Common Stock 10,702 0.00 30,896
2024-03-11 Becker Yin C Officer A-Award A Common Stock 1,509 0.00 29,862
2024-03-08 Berry William E Jr Officer F-InKind D Common Stock 1,005 357.62 359.4K 2,643 D
2024-03-07 Berry William E Jr Officer M-Exempt A Common Stock 7,960 122.51 975.2K 21,335
2024-02-09 Boehnlein Glenn S Officer S-Sale D Common Stock 9,600 342.81 3.29M 20,194
2024-02-07 Stiles Spencer S Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 19,780 339.77 6.72M 19,780
2024-02-07 Pierce James Andrew Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 19,780 339.77 6.72M 19,780
2024-02-07 Menon Viju Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 12,245 339.77 4.16M 12,245
2024-02-07 Lobo Kevin Director / Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 67,695 339.77 23.00M 67,695
2024-02-07 Fletcher Robert S Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 10,830 339.77 3.68M 10,830
2024-02-07 Fink M Kathryn Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 7,065 339.77 2.40M 7,065
2024-02-07 Boehnlein Glenn S Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 21,190 339.77 7.20M 21,190
2024-02-07 Berry William E Jr Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 3,210 339.77 1.09M 3,210
2024-02-07 Becker Yin C Officer A-Award A Employee Stock Option granted 02/07/2024 (right to buy) 3,060 339.77 1.04M 3,060
2024-02-06 STRYKER RONDA E Director / 10% Owner S-Sale D Common Stock 29,626 340.28 10.08M 3,670,806
2024-02-05 STRYKER RONDA E Director / 10% Owner S-Sale D Common Stock 2,006 346.00 694.1K 3,755,128
2024-02-05 Becker Yin C Officer M-Exempt A Common Stock 8,060 93.06 750.1K 33,129
2024-02-02 STRYKER RONDA E Director / 10% Owner M-Exempt D Stock Option granted 2/12/2014 (right to buy) 4,355 81.14 353.4K 0
2024-02-02 Golston Allan C. Director S-Sale D Common Stock 3,273 341.00 1.12M 14,242
2024-01-16 Pierce James Andrew Officer M-Exempt A Common Stock 10,230 81.14 830.1K 57,999
2024-01-11 Boehnlein Glenn S Officer M-Exempt D Employee Stock Option granted 02/10/2016 (right to buy) 49,150 96.64 4.75M 0
2023-12-20 Pierce James Andrew Officer G-Gift D Common Stock 262 0.00 47,769
2023-12-19 Berry William E Jr Officer F-InKind D Common Stock 35 291.47 10.2K 2,874
2023-12-05 Silvernail Andrew K Director M-Exempt A Common Stock 4,355 81.14 353.4K 11,472
2023-12-04 Datar Srikant M. Director M-Exempt A Common Stock 1,795 93.06 167.0K 5,611
2023-12-01 Datar Srikant M. Director S-Sale D Common Stock 500 298.22 149.1K 3,816
2023-11-28 Berry William E Jr Officer S-Sale D Common Stock 573 292.28 167.5K 2,909
2023-11-28 Becker Yin C Officer M-Exempt D Employee Stock Option granted 02/12/2014 (right to buy) 8,875 81.14 720.1K 0
2023-11-27 Boehnlein Glenn S Officer F-InKind D Common Stock 7,594 293.64 2.23M 8,976
2023-11-17 Stiles Spencer S Officer M-Exempt A Common Stock 11,090 81.14 899.8K 53,732
2023-11-17 Lobo Kevin Director / Officer S-Sale D Common Stock 8,060 289.12 2.33M 81,508
2023-11-16 Datar Srikant M. Director S-Sale D Common Stock 500 291.92 146.0K 4,316
2023-11-15 Datar Srikant M. Director S-Sale D Common Stock 500 287.50 143.8K 4,816
2023-11-14 Datar Srikant M. Director S-Sale D Common Stock 750 287.57 215.7K 5,316
2023-11-01 Stiles Spencer S Officer F-InKind D Common Stock 714 270.22 192.9K 42,731
2023-10-01 Stiles Spencer S Officer F-InKind D Common Stock 549 273.27 150.0K 43,445
2023-10-01 Pierce James Andrew Officer F-InKind D Common Stock 627 273.27 171.3K 48,031
2023-09-06 Menon Viju Officer S-Sale D Common Stock 5,000 289.00 1.45M 6,994
2023-08-10 Datar Srikant M. Director S-Sale D Common Stock 750 286.23 214.7K 6,066
2023-08-08 Datar Srikant M. Director M-Exempt A Common Stock 2,000 93.06 186.1K 7,467
2023-08-01 Fletcher Robert S Officer F-InKind D Common Stock 338 283.41 95.8K 7,988
2023-06-09 Lobo Kevin Director / Officer G-Gift D Common Stock 8,904 0.00 80,959
2023-06-05 Lobo Kevin Director / Officer G-Gift D Common Stock 8,904 0.00 80,959
2023-06-01 Datar Srikant M. Director S-Sale D Common Stock 500 278.50 139.3K 5,467
2023-05-18 Datar Srikant M. Director S-Sale D Common Stock 1,000 286.00 286.0K 5,967
2023-05-10 Suri Rajeev Director A-Award A Common Stock 705 0.00 5,215
2023-05-10 Skeete Tatum Lisa M Director A-Award A Common Stock 705 0.00 3,230

Executive team

Top executives
EBIT / Employee
96.6K
Shares Outstanding
382.98M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Kevin A. Lobo Chair, Chief Executive Officer and President 1.49M 9.76M 6.92M 2.25M 974.9K 21.40M 77.96%
2 2025 Spencer S. Stiles Group President, Orthopaedics 792.5K 2.69M 1.90M 760.0K 188.1K 6.33M 72.50%
3 2025 J. Andrew Pierce Group President, MedSurg and Neurotechnology 792.5K 2.69M 1.90M 754.1K 188.1K 6.32M 72.57%
4 2025 Preston W. Wells Vice President, Chief Financial Officer 653.4K 1.84M 1.30M 514.6K 103.3K 4.41M 71.17%
5 2025 Viju S. Menon Group President, Global Quality and Operations 675.0K 1.65M 1.17M 578.0K 167.5K 4.24M 66.47%
6 2025 Glenn S. Boehnlein Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer 800.0K 800.0K 293.0K 1.89M 0.00%
7 2024 Kevin A. Lobo Chair, Chief Executive Officer and President 1.44M 8.70M 8.00M 2.94M 897.9K 21.98M 76.00%
8 2024 Glenn S. Boehnlein Vice President, Chief Financial Officer 793.3K 2.72M 2.51M 1.08M 237.7K 7.34M 71.24%
9 2024 Glenn S. Boehnlein Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer 793.3K 2.72M 2.51M 1.08M 237.7K 7.34M 71.24%
10 2024 J. Andrew Pierce Group President, MedSurg and Neurotechnology 750.0K 2.54M 2.34M 917.3K 211.7K 6.76M 72.20%
11 2024 Spencer S. Stiles Group President, Orthopaedics 750.0K 2.54M 2.34M 917.3K 211.7K 6.76M 72.20%
12 2024 Viju S. Menon Group President, Global Quality and Operations 645.8K 1.57M 1.45M 745.9K 176.2K 4.59M 65.84%
13 2023 Kevin A. Lobo Chair, Chief Executive Officer and President 1.39M 6.65M 8.41M 3.78M 532.7K 20.77M 72.53%
14 2023 Glenn S. Boehnlein Vice President, Chief Financial Officer 755.8K 2.02M 2.55M 1.37M 143.3K 6.84M 66.86%
15 2023 Glenn S. Boehnlein Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer 755.8K 2.02M 2.55M 1.37M 143.3K 6.84M 66.86%
16 2023 J. Andrew Pierce Group President, MedSurg and Neurotechnology 720.8K 1.97M 2.49M 1.17M 131.5K 6.49M 68.77%
17 2023 Spencer S. Stiles Group President, Orthopaedics and Spine 720.8K 1.97M 2.49M 1.17M 129.0K 6.49M 68.80%
18 2023 Spencer S. Stiles Group President, Orthopaedics 720.8K 1.97M 2.49M 1.17M 129.0K 6.49M 68.80%
19 2023 Viju S. Menon Group President, Global Quality and Operations 616.7K 1.23M 1.56M 956.3K 107.8K 4.47M 62.40%
20 2022 Kevin A. Lobo Chair, Chief Executive Officer and President 1.34M 6.53M 8.73M 1.51M 458.5K 18.56M 82.18%
21 2022 Glenn S. Boehnlein Vice President, Chief Financial Officer 730.8K 1.89M 2.53M 546.5K 148.8K 5.85M 75.63%
22 2022 J. Andrew Pierce Group President, MedSurg and Neurotechnology 695.8K 1.89M 2.53M 475.0K 144.9K 5.74M 77.09%
23 2022 Spencer S. Stiles Group President, Orthopaedics and Spine 695.8K 1.89M 2.53M 452.3K 136.7K 5.71M 77.51%
24 2022 Spencer S. Stiles Group President, Orthopaedics 695.8K 1.89M 2.53M 452.3K 136.7K 5.71M 77.51%
25 2022 Viju S. Menon Group President, Global Quality and Operations 571.7K 1.13M 1.51M 363.4K 110.7K 3.68M 71.56%
26 2021 Kevin A. Lobo Chair, Chief Executive Officer and President 1.31M 5.97M 6.80M 1.82M 469.5K 16.36M 78.04%
27 2021 Timothy J. Scannell Executive Advisor 820.8K 2.98M 3.40M 760.9K 156.3K 8.12M 78.60%
28 2021 Glenn S. Boehnlein Vice President, Chief Financial Officer 705.0K 2.63M 1.93M 622.1K 130.8K 6.02M 75.76%
29 2021 J. Andrew Pierce Group President, MedSurg and Neurotechnology 666.7K 2.33M 1.53M 621.8K 117.2K 5.26M 73.29%
30 2021 Spencer S. Stiles Group President, Orthopaedics and Spine 666.7K 2.33M 1.53M 546.8K 117.2K 5.19M 74.35%
31 2021 Viju S. Menon Group President, Global Quality and Operations 551.7K 1.98M 1.19M 435.1K 98.2K 4.26M 74.53%
32 2020 Kevin A. Lobo Chair and CEO 1.11M 5.43M 4.91M 1.43M 430.3K 13.32M 77.67%
33 2020 Kevin A. Lobo Chair, Chief Executive Officer and President 1.11M 5.43M 4.91M 1.43M 430.3K 13.32M 77.67%
34 2020 Timothy J. Scannell Executive Advisor 735.8K 2.62M 2.36M 600.0K 202.0K 6.52M 76.41%
35 2020 Timothy J. Scannell President and COO 735.8K 2.62M 2.36M 600.0K 202.0K 6.52M 76.41%
36 2020 Glenn S. Boehnlein Vice President, Chief Financial Officer 634.2K 1.61M 1.45M 484.5K 162.5K 4.35M 70.52%
37 2020 Glenn S. Boehnlein Vice President, CFO 634.2K 1.61M 1.45M 484.5K 162.5K 4.35M 70.52%
38 2020 Viju S. Menon Group President, Global Quality and Operations 504.9K 956.3K 863.5K 341.1K 307.7K 2.97M 61.20%
39 2020 Robert S. Fletcher Vice President, Chief Legal Officer 504.9K 704.6K 636.2K 300.9K 90.0K 2.24M 59.95%
40 2019 Kevin A. Lobo Chair and CEO 1.23M 5.29M 5.31M 2.63M 510.4K 14.97M 70.80%
41 2019 Kevin A. Lobo Chairman and CEO 1.23M 5.29M 5.31M 2.63M 510.4K 14.97M 70.80%
42 2019 Kevin A. Lobo Chair, Chief Executive Officer and President 1.23M 5.29M 5.31M 2.63M 510.4K 14.97M 70.80%
43 2019 Timothy J. Scannell President and COO 770.8K 2.52M 2.53M 1.10M 193.2K 7.11M 70.98%
44 2019 Timothy J. Scannell Executive Advisor 770.8K 2.52M 2.53M 1.10M 193.2K 7.11M 70.98%
45 2019 Glenn S. Boehnlein Vice President, Chief Financial Officer 650.0K 1.36M 1.37M 843.4K 156.0K 4.38M 62.31%
46 2019 Glenn S. Boehnlein Vice President, CFO 650.0K 1.36M 1.37M 843.4K 156.0K 4.38M 62.31%
47 2019 Robert S. Fletcher Vice President, Chief Legal Officer 357.0K 75.0K 2.32M 356.2K 43.0K 3.15M 73.59%
48 2019 Viju S. Menon Group President, Global Quality and Operations 512.5K 881.5K 885.5K 621.5K 124.2K 3.03M 58.41%
49 2018 Kevin A. Lobo Chair and CEO 1.19M 4.98M 4.61M 2.71M 413.7K 13.91M 68.96%
50 2018 Kevin A. Lobo Chairman and CEO 1.19M 4.98M 4.61M 2.71M 413.7K 13.91M 68.96%
51 2018 Timothy J. Scannell President and COO 691.3K 3.38M 1.43M 986.0K 146.1K 6.63M 72.51%
52 2018 Viju S. Menon Group President, GQO 344.7K 130.0K 1.69M 1.69M 443.5K 95.9K 4.39M 76.92%
53 2018 Viju S. Menon Group President, Global Quality and Operations 344.7K 130.0K 1.69M 1.69M 443.5K 95.9K 4.39M 76.92%
54 2018 David K. Floyd Group President and Advisor to the CEO 636.7K 1.40M 1.29M 692.6K 174.0K 4.19M 64.12%
55 2018 Glenn S. Boehnlein Vice President, CFO 595.0K 1.20M 1.11M 767.8K 123.4K 3.79M 60.77%
56 2018 Lonny J. Carpenter Group President and Advisor to the CEO 540.8K 1.20M 1.11M 688.1K 116.0K 3.65M 63.12%
57 2018 Michael D. Hutchinson Vice President, Chief Legal Officer 520.8K 598.1K 553.0K 592.8K 73.5K 2.34M 49.23%
58 2017 Kevin A. Lobo Chairman and CEO 1.16M 6.18M 4.34M 1.89M 431.8K 14.01M 75.10%
59 2017 Kevin A. Lobo Chairman, President and Chief Executive Officer 1.16M 6.18M 4.34M 1.89M 431.8K 14.01M 75.10%
60 2017 Timothy J. Scannell Group President, MedSurg and Neurotechnology 631.7K 1.91M 1.33M 636.9K 154.2K 4.66M 69.46%
61 2017 Timothy J. Scannell President and COO 631.7K 1.91M 1.33M 636.9K 154.2K 4.66M 69.46%
62 2017 David K. Floyd Group President, Orthopaedics 613.3K 1.70M 1.23M 606.4K 133.5K 4.29M 68.44%
63 2017 David K. Floyd Group President and Advisor to the CEO 613.3K 1.70M 1.23M 606.4K 133.5K 4.29M 68.44%
64 2017 Lonny J. Carpenter Group President, Global Quality and Business Operations 516.7K 1.45M 1.05M 510.9K 109.0K 3.63M 68.72%
65 2017 Lonny J. Carpenter Group President and Advisor to the CEO 516.7K 1.45M 1.05M 510.9K 109.0K 3.63M 68.72%
66 2017 Glenn S. Boehnlein Vice President, Chief Financial Officer 577.6K 999.1K 914.2K 527.1K 123.2K 3.14M 60.91%
67 2017 Glenn S. Boehnlein Vice President, CFO 577.6K 999.1K 914.2K 527.1K 123.2K 3.14M 60.91%
68 2016 Kevin A. Lobo Chairman, President and Chief Executive Officer 1.13M 5.39M 3.67M 2.28M 336.3K 12.80M 70.76%
69 2016 Kevin A. Lobo Chairman and CEO 1.13M 5.39M 3.67M 2.28M 336.3K 12.80M 70.76%
70 2016 Timothy J. Scannell Group President, MedSurg and Neurotechnology 610.3K 1.91M 1.33M 769.8K 146.2K 4.77M 68.00%
71 2016 Timothy J. Scannell President and COO 610.3K 1.91M 1.33M 769.8K 146.2K 4.77M 68.00%
72 2016 David K. Floyd Group President and Advisor to the CEO 575.0K 1.60M 1.15M 600.6K 127.2K 4.05M 67.83%
73 2016 David K. Floyd Group President, Orthopaedics 575.0K 1.60M 1.15M 600.6K 127.2K 4.05M 67.83%
74 2016 Lonny J. Carpenter Group President and Advisor to the CEO 497.5K 1.33M 962.7K 573.1K 93.9K 3.46M 66.33%
75 2016 Lonny J. Carpenter Group President, Global Quality and Business Operations 497.5K 1.33M 962.7K 573.1K 93.9K 3.46M 66.33%
76 2016 Glenn S. Boehnlein Vice President, CFO 517.3K 964.3K 871.0K 542.3K 91.4K 2.99M 61.46%
77 2016 Glenn S. Boehnlein Vice President, Chief Financial Officer 517.3K 964.3K 871.0K 542.3K 91.4K 2.99M 61.46%
78 2016 Glenn S. Boehnlein Vice President and Chief Financial Officer 517.3K 964.3K 871.0K 542.3K 91.4K 2.99M 61.46%
79 2016 William R. Jellison Advisor to the Chief Financial Officer and Former 554.0K 387.8K 114.3K 1.06M 0.00%
80 2015 Kevin A. Lobo Chairman, President and Chief Executive Officer 1.09M 3.65M 3.54M 1.93M 265.5K 10.47M 68.61%
81 2015 Timothy J. Scannell Group President, MedSurg and Neurotechnology 584.3K 1.68M 1.28M 718.7K 125.4K 4.40M 67.51%
82 2015 David K. Floyd Group President, Orthopaedics 545.0K 1.17M 945.0K 644.8K 98.0K 3.40M 62.12%
83 2015 Lonny J. Carpenter Group President, Global Quality and Business Operations 481.7K 1.26M 872.3K 441.9K 85.4K 3.14M 67.88%
84 2015 William R. Jellison Advisor to the Chief Financial Officer and Former 551.5K 624.3K 605.8K 485.5K 99.2K 2.37M 51.99%
85 2015 William R. Jellison Vice President, Chief Financial Officer 551.5K 624.3K 605.8K 485.5K 99.2K 2.37M 51.99%
86 2014 Kevin A. Lobo Chairman, President and Chief Executive Officer 1.06M 3.25M 3.23M 1.32M 263.5K 9.12M 71.07%
87 2014 Kevin A. Lobo Chairman, President and Chief Executive Officer 1.06M 3.25M 3.23M 1.32M 263.5K 9.12M 71.07%
88 2014 Timothy J. Scannell Group President, MedSurg and Neurotechnology 568.5K 1.05M 1.04M 555.2K 106.5K 3.32M 62.99%
89 2014 Timothy J. Scannell Group President, MedSurg and Spine 568.5K 1.05M 1.04M 555.2K 106.5K 3.32M 62.99%
90 2014 Ramesh Subrahmanian Group President, International 526.7K 800.0K 795.5K 288.2K 515.1K 2.93M 54.54%
91 2014 David K. Floyd Group President, Orthopaedics 513.3K 800.0K 795.5K 346.2K 85.6K 2.54M 62.80%
92 2014 David K. Floyd Group President, Orthopaedics 513.3K 800.0K 795.5K 346.2K 85.6K 2.54M 62.80%
93 2014 William R. Jellison Vice President, Chief 536.7K 624.9K 621.4K 350.2K 86.3K 2.22M 56.15%
94 2014 William R. Jellison Advisor to the Chief Financial Officer and Former 536.7K 624.9K 621.4K 350.2K 86.3K 2.22M 56.15%
95 2014 William R. Jellison Vice President, Chief Financial Officer 536.7K 624.9K 621.4K 350.2K 86.3K 2.22M 56.15%
96 2013 Kevin A. Lobo Chairman, President and Chief Executive Officer 1.03M 3.00M 2.85M 1.34M 217.7K 8.44M 69.39%
97 2013 Kevin A. Lobo President and Chief Executive Officer 1.03M 3.00M 2.85M 1.34M 217.7K 8.44M 69.39%
98 2013 Kevin A. Lobo Chairman, President and Chief Executive Officer 1.03M 3.00M 2.85M 1.34M 217.7K 8.44M 69.39%
99 2013 Ramesh Subrahmanian Group President, International 512.5K 749.9K 713.6K 345.2K 874.9K 3.20M 45.79%
100 2013 Timothy J. Scannell Group President, MedSurg and Neurotechnology 553.3K 1,000.0K 951.4K 399.9K 99.9K 3.00M 64.95%
101 2013 Timothy J. Scannell Group President, MedSurg and Spine 553.3K 1,000.0K 951.4K 399.9K 99.9K 3.00M 64.95%
102 2013 David K. Floyd Group President, Orthopaedics 477.5K 749.9K 713.6K 416.0K 471.0K 2.83M 51.75%
103 2013 David K. Floyd Group President, Orthopaedics 477.5K 749.9K 713.6K 416.0K 471.0K 2.83M 51.75%
104 2013 William R. Jellison Vice President, Chief Financial Officer 363.9K 67.5K 985.7K 974.1K 248.2K 174.0K 2.81M 69.66%
105 2013 William R. Jellison Vice President, Chief 363.9K 67.5K 985.7K 974.1K 248.2K 174.0K 2.81M 69.66%
106 2013 Dean H. Bergy Vice President, 349.8K 205.2K 120.2K 122.0K 73.8K 78.3K 949.3K 25.52%
107 2012 Stephen P. MacMillan Formerly Chairman, President and Chief 208.3K 1.99M 3.78M 5.60M 11.59M 49.85%
108 2012 Kevin A. Lobo President and Chief 585.4K 80.0K 5.93M 1.79M 465.4K 376.4K 9.23M 83.67%
109 2012 Kevin A. Lobo Chairman, President and Chief Executive Officer 585.4K 80.0K 5.93M 1.79M 465.4K 376.4K 9.23M 83.67%
110 2012 Kevin A. Lobo President and Chief Executive Officer 585.4K 80.0K 5.93M 1.79M 465.4K 376.4K 9.23M 83.67%
111 2012 Curt R. Hartman Formerly Vice President and Chief Financial 708.3K 2.19M 699.8K 565.5K 1.75M 5.91M 48.91%
112 2012 Ramesh Subrahmanian 500.0K 1.11M 374.2K 246.1K 551.5K 2.78M 53.36%
113 2012 Ramesh Subrahmanian Group President, International 500.0K 1.11M 374.2K 246.1K 551.5K 2.78M 53.36%
114 2012 Timothy J. Scannell Group President, MedSurg and Spine 507.2K 1.26M 482.7K 354.7K 87.4K 2.69M 64.67%
115 2012 Lonny J. Carpenter Group President, 407.4K 1.11M 374.2K 226.2K 68.1K 2.19M 67.90%
116 2012 Dean H. Bergy Vice President and Chief Financial Officer 320.7K 97.0K 120.0K 97.0K 59.6K 38.1K 732.5K 29.64%
117 2012 Dean H. Bergy Advisor to the Vice President and Chief Financial Officer 320.7K 97.0K 120.0K 97.0K 59.6K 38.1K 732.5K 29.64%
118 2011 Stephen P. MacMillan Chairman, President and Chief Executive Officer 1.25M 3.60M 3.11M 1.17M 418.4K 9.54M 70.29%
119 2011 Stephen P. MacMillan Formerly Chairman, President and Chief 1.25M 3.60M 3.11M 1.17M 418.4K 9.54M 70.29%
120 2011 Andrew G. Fox-Smith Advisor to the Chief Executive Officer and Former Group President, International 441.5K 704.9K 609.2K 297.1K 471.2K 2.52M 52.07%
121 2011 Kevin A. Lobo President and Chief Executive Officer 288.8K 479.7K 428.4K 162.0K 950.8K 2.31M 39.32%
122 2011 Kevin A. Lobo President and Chief 288.8K 479.7K 428.4K 162.0K 950.8K 2.31M 39.32%
123 2011 Kevin A. Lobo President and Chief Executive Officer 288.8K 479.7K 428.4K 162.0K 950.8K 2.31M 39.32%
124 2011 Curt R. Hartman Vice President and Chief Financial Officer 500.0K 719.6K 622.0K 327.6K 99.9K 2.27M 59.12%
125 2011 Curt R. Hartman Formerly Vice President and Chief Financial 500.0K 719.6K 622.0K 327.6K 99.9K 2.27M 59.12%
126 2011 Timothy J. Scannell Group President, MedSurg and Spine 460.0K 687.6K 594.3K 270.1K 98.4K 2.11M 60.74%
127 2011 Lonny J. Carpenter Group President and Advisor to the CEO 362.0K 533.1K 460.7K 210.9K 76.6K 1.64M 60.47%
128 2011 Lonny J. Carpenter Group President, 362.0K 533.1K 460.7K 210.9K 76.6K 1.64M 60.47%
129 2010 Stephen P. MacMillan Chairman, President and Chief Executive Officer 1.20M 1.91M 1.38M 225.2K 4.71M 40.49%
130 2010 Stephen P. MacMillan Formerly Chairman, President and Chief 1.20M 1.91M 1.14M 225.2K 4.71M 40.49%
131 2010 Michael P. Mogul Group President, Orthopaedics 490.0K 1.19M 470.1K 650.5K 2.80M 42.42%
132 2010 Andrew G. Fox-Smith Group President, International 431.5K 1.19M 311.8K 382.2K 2.31M 51.32%
133 2010 Andrew G. Fox-Smith Advisor to the Chief Executive Officer and Former Group President, International 431.5K 1.19M 311.8K 382.2K 2.31M 51.32%
134 2010 Curt R. Hartman Vice President and Chief Financial Officer 430.0K 34.5K 1.09M 295.5K 60.9K 1.91M 57.05%
135 2010 Curt R. Hartman Formerly Vice President and Chief Financial 430.0K 35.5K 1.09M 295.5K 60.9K 1.91M 57.05%
136 2010 Timothy J. Scannell Group President, MedSurg and Spine 435.0K 1.09M 295.2K 61.6K 1.88M 57.94%
137 2009 Stephen P. MacMillan Chairman, President and Chief Executive Officer 1.20M 1.96M 540.0K 208.5K 3.91M 50.19%
138 2009 Andrew G. Fox-Smith Advisor to the Chief Executive Officer and Former Group President, International 412.3K 9.7K 607.5K 1.21M 147.4K 379.3K 2.77M 65.71%
139 2009 Andrew G. Fox-Smith Group President, International 412.3K 9.7K 607.5K 1.21M 147.4K 379.3K 2.77M 65.71%
140 2009 Michael P. Mogul Group President, Orthopaedics 446.7K 31.6K 607.5K 1.21M 277.6K 113.0K 2.69M 67.66%
141 2009 Michael P. Mogul Group President, Orthopaedics 446.7K 31.6K 607.5K 1.21M 277.6K 113.0K 2.69M 67.66%
142 2009 Timothy J. Scannell Group President, MedSurg and Spine 415.0K 607.5K 1.11M 124.7K 65.6K 2.33M 73.97%
143 2009 Timothy J. Scannell Group President, MedSurg and Spine 415.0K 607.5K 1.11M 124.7K 65.6K 2.33M 73.97%
144 2009 Curt R. Hartman Vice President and Chief Financial Officer 410.0K 9.2K 607.5K 1.11M 114.0K 59.8K 2.31M 74.36%
145 2009 Dean H. Bergy Advisor to the Vice President and Chief Financial Officer 450.0K 66.2K 516.2K 0.00%
146 2008 Stephen P. MacMillan President and Chief Executive Officer 1.20M 280.6K 617.3K 300.8K 5.90M 4.75%
147 2008 Stephen Si Johnson Vice President; Group President, MedSurg 545.0K 369.5K 142.6K 2.62M 0.00%
148 2008 James E. Kemler Vice President; Group President, BOD 460.0K 215.4K 111.7K 2.21M 0.00%
149 2008 Stephen P. MacMillan Chairman, President and Chief Executive Officer 1.20M 617.3K 300.8K 2.12M 0.00%
150 2008 Andrew G. Fox-Smith Group President, International 400.4K 1.09M 125.5K 361.1K 1.98M 55.22%
151 2008 Dean H. Bergy Vice President and Chief Financial Officer 450.0K 149.3K 96.3K 1.75M 0.00%
152 2008 Dean H. Bergy Advisor to the Vice President and Chief Financial Officer 450.0K 1.05M 149.3K 96.3K 1.75M 60.15%
153 2008 Curt R. Hartman Vice President, Finance 360.7K 132.0K 63.2K 1.48M 0.00%
154 2008 Curt R. Hartman Vice President and Chief Financial Officer 360.7K 875.2K 132.0K 63.2K 1.43M 61.16%
155 2007 Stephen P. MacMillan President and Chief Executive Officer 950.0K 673.4K 1.10M 233.1K 6.59M 10.22%
156 2007 Stephen Si Johnson Vice President; Group President, MedSurg 526.3K 527.7K 117.3K 2.56M 0.00%
157 2007 Luciano Cattani Vice President; Group President, International 882.3K 419.9K 122.1K 2.32M 0.00%
158 2007 Stephen P. MacMillan Chairman, President and Chief Executive Officer 950.0K 1.10M 233.1K 2.28M 0.00%
159 2007 James E. Kemler Vice President; Group President, Biotech, Spine, Osteosynthesis and Development 446.7K 389.7K 93.2K 2.19M 0.00%
160 2007 James E. Kemler Vice President; Group President, BOD 446.7K 389.7K 93.2K 2.19M 0.00%
161 2007 Dean H. Bergy Advisor to the Vice President and Chief Financial Officer 400.0K 1.20M 356.4K 94.5K 2.06M 58.60%
162 2007 Dean H. Bergy Vice President and Chief Financial Officer 400.0K 356.4K 94.5K 1.74M 0.00%
163 2006 Stephen P. MacMillan President and Chief Executive Officer 900.0K 673.4K 877.5K 207.0K 6.07M 11.09%
164 2006 Stephen Si Johnson Vice President; Group President, MedSurg 498.8K 108.0K 287.0K 114.8K 2.39M 0.00%
165 2006 James E. Kemler Vice President; Group President, BOD 423.3K 32.2K 287.8K 76.8K 2.00M 0.00%
166 2006 James E. Kemler Vice President; Group President, Biotech, Spine, Osteosynthesis and Development 423.3K 32.2K 287.8K 76.8K 2.00M 0.00%
167 2006 Luciano Cattani Vice President; Group President, International 781.0K 90.1K 161.1K 92.2K 1.96M 0.00%
168 2006 Dean H. Bergy Vice President and Chief Financial Officer 355.0K 312.0K 83.4K 1.51M 0.00%
169 2005 Stephen P. MacMillan President and Chief Executive Officer 800.0K 743.0K 164.5K 1.71M 0.00%
170 2005 Stephen Si Johnson Vice President; Group President, MedSurg 466.3K 415.0K 97.0K 978.3K 0.00%
171 2005 James R. Lawson Vice President; Group President, Global 525.0K 300.0K 111.1K 936.1K 0.00%
172 2005 James E. Kemler Vice President; Group President, Biotech, Spine, 398.3K 275.0K 74.5K 747.9K 0.00%
173 2005 Dean H. Bergy Vice President and Chief Financial Officer 325.0K 288.0K 66.0K 679.0K 0.00%
174 2004 Stephen P. MacMillan President and Chief Executive Officer 608.3K 635.0K 112.6K 1.36M 0.00%
175 2004 James R. Lawson Vice President; Group President, Global 500.0K 485.0K 97.4K 1.08M 0.00%
176 2004 Stephen Si Johnson Vice President; Group President, MedSurg 441.3K 416.0K 84.3K 941.5K 0.00%
177 2004 James E. Kemler Vice President; Group President, Biotech, Spine, 378.3K 275.0K 61.5K 714.8K 0.00%
178 2004 Dean H. Bergy Vice President and Chief Financial Officer 275.0K 275.0K 57.8K 607.8K 0.00%
179 2003 Stephen P. MacMillan President and Chief Executive Officer 320.8K 650.0K 3.37M 16.6K 4.35M 77.32%
180 2003 James R. Lawson Vice President; Group President, Global 475.0K 385.0K 85.3K 945.3K 0.00%
181 2003 Stephen Si Johnson Vice President; Group President, MedSurg 416.3K 325.0K 80.4K 821.7K 0.00%
182 2003 James E. Kemler Vice President; Group President, Biotech, Spine, 350.0K 185.0K 60.5K 595.5K 0.00%
183 2003 Dean H. Bergy Vice President and Chief Financial Officer 250.0K 250.0K 44.0K 544.0K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-03-23 DEFA14A
2026-03-23 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-11 10-Q
2026-05-08 8-K
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 4
2026-05-08 4

Executive team

NameTitleCompensationGender
Kevin A. Lobo Chairman & CEO 5M male
Glenn S. Boehnlein Advisor 2M male
Spencer S. Stiles President & COO 2M male
J. Andrew Pierce Group President of MedSurg & Neurotechnology 2M male
Preston Wells Vice President & Chief Financial Officer 1M male
Viju S. Menon Group President of Global Quality & Operations 1M male
Robert S. Fletcher Vice President & Chief Legal Officer 895.9K male
William E. Berry Jr. Vice President & Chief Accounting Officer male
Dana S. McMahon Vice President & Chief Compliance Officer female
Debra S. King VP and Chief Digital & Information Officer female
Jason Beach Vice President of Finance & Investor Relations male
Robert C. Cohen Chief Technology Officer and Vice President of Global R&D - Joint Replacement male
ESG Rating
B
MEDICAL - DEVICES
2013
E (Environmental)
74.6 / 62.5
Company / Sector avg.
S (Social)
56.8 / 68.9
Company / Sector avg.
G (Governance)
66.6 / 64.8
Company / Sector avg.
ESG Total
66.0 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2022-11-30 2022-12-21 Dan Sullivan AK Joint Sale (Full) $1,001 - $15,000
2020-04-14 2020-05-08 David Perdue Joint Sale (Full) $1,001 - $15,000
2019-09-30 2019-11-05 David Perdue Joint Sale (Partial) $1,001 - $15,000
2019-02-28 2019-03-18 John Reed RI Self Sale (Full) $15,001 - $50,000
2019-02-28 2019-03-18 John Reed RI Joint Sale (Full) $1,001 - $15,000
2019-02-04 2019-03-01 John Reed RI Joint Sale (Partial) $1,001 - $15,000
2018-03-09 2018-03-12 John Reed RI Joint Sale (Partial) $1,001 - $15,000
2017-10-30 2017-11-02 David Perdue Joint Sale (Partial) $1,001 - $15,000
2017-08-24 2017-09-12 Sheldon Whitehouse RI Self Purchase $1,001 - $15,000
2017-05-24 2017-06-06 David Perdue Joint Sale (Partial) $1,001 - $15,000
2016-09-08 2016-10-11 Susan M. Collins ME Spouse Purchase $50,001 - $100,000
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2026-01-23 2026-02-20 Thomas H. Kean NJ07 Sale $15,001 - $50,000
2025-12-10 2026-01-12 Gilbert Cisneros CA31 Purchase $1,001 - $15,000
2025-11-20 2025-12-19 Thomas H. Kean NJ07 Sale $15,001 - $50,000
2025-11-18 2025-12-15 Gilbert Cisneros CA31 Purchase $1,001 - $15,000
2025-10-17 2025-11-18 Gilbert Cisneros CA31 Purchase $1,001 - $15,000
2025-10-16 2026-01-13 Julia Letlow LA05 Sale (Full) $1,001 - $15,000
2025-10-07 2025-11-14 Ro Khanna CA17 Spouse Sale $1,001 - $15,000
2025-09-12 2025-10-15 Thomas H. Kean NJ07 Sale $15,001 - $50,000
2025-08-25 2025-09-19 Thomas H. Kean NJ07 Sale $1,001 - $15,000
2025-07-31 2025-08-21 Thomas H. Kean NJ07 Sale $15,001 - $50,000
2025-06-26 2025-07-17 Thomas H. Kean NJ07 Sale $15,001 - $50,000
2025-04-08 2025-05-08 Rob Bresnahan PA08 Sale (Full) $1,001 - $15,000
2025-04-07 2025-05-12 Jared Moskowitz FL23 Purchase $1,001 - $15,000
2025-03-13 2025-04-14 Jefferson Shreve IN06 Sale $50,001 - $100,000
2025-02-26 2025-03-14 Thomas H. Kean NJ07 Sale $15,001 - $50,000
2025-01-15 2025-02-11 Jared Moskowitz FL23 Purchase $1,001 - $15,000
2024-10-23 2026-01-13 Julia Letlow LA05 Purchase $1,001 - $15,000
2024-10-14 2024-11-11 Ro Khanna CA17 Purchase $1,001 - $15,000
2024-09-13 2024-10-08 Ro Khanna CA17 Spouse Sale $1,001 - $15,000
2024-03-22 2024-04-05 Ro Khanna CA17 Spouse Sale $1,001 - $15,000
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits